Seelos Therapeutics Inc. (NASDAQ: SEEL)
$0.57
+0.0488 ( +9.41% ) 391.0K
Seelos Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders. Its product pipeline includes SLS-002, SLS-005, SLS-004, SLS-007, and SLS-009.
Market Data
Open
$0.57
Previous close
$0.52
Volume
391.0K
Market cap
$1.60M
Day range
$0.51 - $0.57
52 week range
$0.47 - $398.40
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 24 | Mar 19, 2024 |
| 10-k | Annual reports | 81 | Mar 06, 2024 |
| 4 | Insider transactions | 1 | Mar 01, 2024 |
| 8-k | 8K-related | 19 | Jan 30, 2024 |
| 8-k | 8K-related | 14 | Jan 22, 2024 |
| 4 | Insider transactions | 1 | Jan 17, 2024 |
| 4 | Insider transactions | 1 | Jan 17, 2024 |
| 8-k | 8K-related | 17 | Jan 10, 2024 |
| 4 | Insider transactions | 1 | Jan 08, 2024 |
| 4 | Insider transactions | 1 | Jan 08, 2024 |